Catherine Owen appointed as CEO of Acadia Pharmaceuticals
by
Contributor since / Followers
Contributor since / Followers
2 months ago
- Acadia Pharmaceuticals (NASDAQ:ACAD) announced that Catherine Owen Adams has succeeded Steve Davis as Chief Executive Officer and joined the Acadia Board of Directors.
- Most recently, she served as Senior Vice President and General Manager, U.S., at Bristol Myers Squibb.
- Source: Press Release